These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12323006)

  • 1. Study of the causes of higher mortality rates from chronic liver diseases in Tokushima Prefecture.
    Kamamura M; Honda H; Inoue H; Shinomiya H; Kubo K; Tsutsui A; Muguruma N; Shibata H; Shimizu I; Ito S
    J Med Invest; 2002 Aug; 49(3-4):163-71. PubMed ID: 12323006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
    Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for hepatitis A and B antibodies in patients with chronic liver disease.
    Lau DT; Hewlett AT
    Am J Med; 2005 Oct; 118 Suppl 10A():28S-33S. PubMed ID: 16271538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HBs Ag and antibodies to hepatitis C virus in complicated chronic liver disease in Gabon. A case control study].
    Perret JL; Moussavou-Kombila JB; Delaporte E; Pemba LF; Boguikouma JB; Matton T; Larouze B
    Gastroenterol Clin Biol; 2002 Feb; 26(2):131-5. PubMed ID: 11938063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
    Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of antigen HBs and antivirus antibodies of hepatitis C during hepatopathies in Mali].
    Dembele M; Maïga I; Minta D; Konate A; Diarra M; Sangare D; Traore HA; Maïga MY; Tounkara A; Payan C; Lunel E; Carbonnelle B; Cales P
    Bull Soc Pathol Exot; 2004 Aug; 97(3):161-4. PubMed ID: 15462194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of dual infection of hepatitis B and C viruses among patients with chronic liver disease: a study from tertiary care hospital.
    Chakravarti A; Verma V; Jain M; Kar P
    Trop Gastroenterol; 2005; 26(4):183-7. PubMed ID: 16737047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic liver disease mortality in the United States, 1990-1998.
    Vong S; Bell BP
    Hepatology; 2004 Feb; 39(2):476-83. PubMed ID: 14768001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endemic hepatitis B virus infection and chronic liver disease mortality in the Republic of Palau, 1990-2002.
    Vogt TM; Goldstein ST; Kuartei S
    Trans R Soc Trop Med Hyg; 2006 Dec; 100(12):1130-4. PubMed ID: 16765396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical investigation of HCV antibodies positive cases in the district with high mortality rate of liver diseases in Saga Prefecture].
    Hara T; Setoguchi Y; Yamamoto K; Ozaki I; Wada I; Fukusima N; Mizuta T; Kajihara S; Sakai T
    Fukuoka Igaku Zasshi; 1993 Feb; 84(2):54-7. PubMed ID: 8390393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of hepatitis B and C virus infections among Lao blood donors.
    Jutavijittum P; Yousukh A; Samountry B; Samountry K; Ounavong A; Thammavong T; Keokhamphue J; Toriyama K
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):674-9. PubMed ID: 17883005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases.
    Georgiadou SP; Zachou K; Rigopoulou E; Liaskos C; Mina P; Gerovasilis F; Makri E; Dalekos GN
    J Viral Hepat; 2004 Jul; 11(4):358-65. PubMed ID: 15230859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of chronic hepatitis B: a retrospective study.
    Wu GC; Zhou WP; Zhao YR; Guo SH; Wang ZY; Zou SB; Zhang QH; Ren H; Huang AL; Zhang DF
    Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):566-70. PubMed ID: 14627521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of patients with HCC who are negative for both HBV and HCV markers.
    Watabe H; Shiratori Y; Tateishi R; Fujishima T; Akamatsu M; Koike Y; Obi S; Hamamura K; Sato S; Teratani T; Shiina S; Omata M
    Hepatogastroenterology; 2003; 50(54):2157-60. PubMed ID: 14696486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural histories of hepatitis C virus infection in men and women simulated by the Markov model.
    Tanaka J; Kumada H; Ikeda K; Chayama K; Mizui M; Hino K; Katayama K; Kumagai J; Komiya Y; Miyakawa Y; Yoshizawa H
    J Med Virol; 2003 Jul; 70(3):378-86. PubMed ID: 12767000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
    Khan A; Kurbanov F; Tanaka Y; Elkady A; Sugiyama M; Dustov A; Mizokami M
    J Med Virol; 2008 Feb; 80(2):268-76. PubMed ID: 18098133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.